NCT00398580View on ClinicalTrials.gov

28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
HypogonadismHypogonadism, Male
Interventions
DRUG

Nanomilled testosterone

DRUG

Nanomilled dutasteride

DRUG

commercially available dutasteride

Trial Locations (7)

21287

GSK Investigational Site, Baltimore

27710

GSK Investigational Site, Durham

40202

GSK Investigational Site, Louisville

78229

GSK Investigational Site, San Antonio

90502

GSK Investigational Site, Torrance

98108

GSK Investigational Site, Seattle

98195

GSK Investigational Site, Seattle

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00398580 - 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men | Biotech Hunter | Biotech Hunter